Related Experiment Videos
Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes
Abstract:
Removal of beta 2-microglobulin (B2MG) from uremic plasma during hemofiltration in 5 patients using polysulfone (F60), acrylonitrile (AN69), polyamid (FH77), polyacrylonitrile (PAN200) and cellulose-acetate (Duo-Flux) membranes was investigated. The reduction in plasma concentration of B2MG (corrected for hemoconcentration during treatment) was greatest for the F60 hemofilter (61%, sieving coefficient 0.55 at end of treatment) and the AN69 (48%, sieving coefficient 0.45 at end of treatment, while the PAN200 membrane showed no reduction in plasma concentration of B2MG during treatment. Mass balance for B2MG showed that there was a continued net adsorption of B2MG in the AN69 membrane (about 120 mg) throughout the treatment, while insignificant amount of B2MG was absorbed by the F60 membrane. The results with the PAN200 showed a 'negative adsorption', indicating release of B2MG from cells into the plasma as blood passed through this filter. Comparison of reduction in plasma concentrations, sieving coefficients, plasma clearances and filter mass balances showed that the question of B2MG removal during hemofiltration is a complex issue where adsorption to the membrane, 'shedding' from blood cells, membrane pore size and possibly also 'redistribution' of B2MG in the body must be considered.
Insights
Different hemofiltration membranes vary in their removal of beta 2-microglobulin (B2MG). Polysulfone (F60) and acrylonitrile (AN69) membranes showed the greatest B2MG reduction, while polyacrylonitrile (PAN200) did not reduce B2MG levels.
Area of Science:
- Nephrology
- Biomaterials Science
- Hemodialysis Technology
Background:
- Beta 2-microglobulin (B2MG) is a protein that accumulates in patients with kidney failure.
- Effective removal of B2MG during hemofiltration is crucial for managing uremic complications.
- Various synthetic membranes are used in hemofiltration, each with potentially different B2MG removal characteristics.
Purpose of the Study:
- To investigate and compare the efficiency of different hemofiltration membranes in removing beta 2-microglobulin (B2MG) from uremic plasma.
- To analyze the factors influencing B2MG removal, including membrane type, adsorption, and potential release from blood cells.
Main Methods:
- Studied B2MG removal in 5 patients undergoing hemofiltration using polysulfone (F60), acrylonitrile (AN69), polyamid (FH77), polyacrylonitrile (PAN200), and cellulose-acetate (Duo-Flux) membranes.
- Measured plasma concentrations of B2MG, corrected for hemoconcentration.
- Calculated sieving coefficients and performed mass balance analysis for B2MG across each membrane.
Main Results:
- Polysulfone (F60) and acrylonitrile (AN69) membranes demonstrated the highest B2MG reduction (61% and 48%, respectively).
- The polyacrylonitrile (PAN200) membrane showed no reduction in B2MG plasma concentration and indicated 'negative adsorption' (release from cells).
- Mass balance revealed significant B2MG adsorption with AN69, minimal adsorption with F60, and release with PAN200.
Conclusions:
- Hemofiltration membrane choice significantly impacts beta 2-microglobulin (B2MG) removal efficiency.
- B2MG removal is complex, influenced by membrane properties, B2MG adsorption to the filter, and potential shedding from blood cells.
- Further research is needed to understand B2MG redistribution and optimize hemofiltration strategies for uremic patients.